Honasa Consumer shares surged 10% to hit a 52-week high of ₹398 on Friday's trading session, as reported by Business Standard. The stock price surpassed its previous high of ₹364.80 touched on May 15, 2026, and reached a record high of ₹546.50 on September 10, 2024. At 09:28 AM, the stock was trading 8% higher at ₹389.95, significantly outperforming the BSE Sensex's 0.41% rise. Average trading volumes jumped over six-fold, with a combined 11.29 million equity shares changing hands on the NSE and BSE exchanges.
According to Business Standard reports, Honasa Consumer reported its highest-ever quarterly revenue of ₹682 crore in Q4FY26, growing 28% year-on-year driven by healthy volume growth. The company achieved its highest-ever profit after tax (PAT) of ₹69 crore, more than doubling from ₹25 crore in Q4FY25. EBITDA jumped 186% YoY to ₹77 crore, with margins improving significantly to 11.7% from 5.1% in Q4FY25. The like-to-like sales growth was 28% YoY, while ex-Reginald LTL sales growth was estimated at 21-22% YoY with 30% underlying volume growth. As per latest reports, consolidated net profit for Q4 FY26 reached ₹69.19 crore, registering a 176.98% year-on-year increase from ₹24.98 crore in the corresponding quarter last year. Revenue from operations rose 23.15% to ₹657.08 crore compared with ₹533.56 crore a year earlier.
As reported by Business Standard, Mamaearth delivered teen growth in Q4FY26 and further strengthened its offline distribution ecosystem, with 1.2 lakh outlets billed directly through distributors during FY26. The company's younger brands grew over 40% YoY in FY26, maintaining strong momentum across online and offline channels. The board approved its maiden final dividend of ₹3 per equity share, reflecting confidence in the business direction. Management commented on delivering three consecutive quarters of 20%+ growth, with Q4FY26 becoming the highest-ever quarter in both revenue and EBITDA. During FY26, The Derma Co also continued delivering strong growth while maintaining a double-digit EBITDA profile.
According to JM Financial Institutional Securities analysis reported by Business Standard, the brokerage maintained a 'BUY' rating with a revised target price of ₹420, up from the earlier ₹375. The firm raised its FY26-28E estimates by 9-12% factoring in strong Q4 performance, upbeat outlook, and the Reginald acquisition. Key positives included Mamaearth sales growing in mid-teens while young brands sustained 30%+ growth, with scale leverage and marketing efficiencies leading to LTL EBITDA margins expanding to 11%+. The management expects to sustain double-digit growth momentum for Mamaearth led by traction in focused categories and distribution expansion. Jefferies maintained a 'Buy' rating with a target price of ₹565, saying Honasa Consumer was firmly back on a stronger growth trajectory after a challenging period related to distribution restructuring. CLSA retained an 'Outperform' rating with a target price of ₹434, highlighting that EBITDA margins expanded by more than 650 basis points year-on-year and noting that management expects Mamaearth to continue delivering double-digit growth.
For the full financial year FY26, consolidated net profit more than doubled to ₹200.19 crore from ₹72.68 crore in the previous year. Total consolidated income increased 15.37% to ₹2,475.52 crore for the full year. The board also approved its maiden final dividend of ₹3 per equity share, amounting to 51.2% of FY26 standalone profit after tax, reflecting confidence in the business direction and strong cash generation capabilities.
